Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06987383 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vibegron for ENergy Thinking and Resilience in Aging

Study acronym: VENTURA
StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Oct 2026 to Nov 2026
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 2 of 2 entries
  2. Start date: Sep 2026 to Oct 2026v5
  3. Start date: Aug 2026 to Sep 2026v4
  4. Collaborators expanded, about 5 words
    • Study title shortened, about 5 words
    v3
  5. Primary and study completion dates: Jun 2027 to Jul 2028
    • Start date: Jul 2025 to Aug 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This 12-week randomized, double-blind, placebo-controlled trial will test the hypothesis that Vibegron (brand name GEMTESA) can improve energy metabolism, cardiometabolic risk factors, and physical and cognitive function in middle-aged and older adults with obesity.
Trial Details
NCT Number NCT06987383
Lead Sponsor Wake Forest University Health Sciences
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)		 Obesity
Related terms Obesity
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov